Most Clicked StoriesMore >


Triple vs. dual antithrombotic therapy

AJMPlus | Jun 09, 2016

The role of triple antithrombotic therapy vs. dual antithrombotic therapy in patients with both atrial fibrillation and coronary artery disease remains unclear. This study explores the differences in treatment practices and outcomes between triple antithrombotic therapy and dual antithrombotic therapy in patients with atrial fibrillation and coronary artery disease. The American Journal of Medicine (06/2016)


Biomarkers for heart failure

AJMPlus | Jun 02, 2016

HAS-BLED, ATRIA and ORBIT bleeding risk scores in atrial fibrillation patients taking warfarin

AJMPlus | Jun 16, 2016

Multiple chronic conditions in acute coronary syndrome

AJMPlus | Jun 23, 2016

Statins and kidney disease outcomes

AJMPlus | Jun 02, 2016

Safety and pharmacokinetics of pravastatin in high-risk pregnancy

AJMPlus | Jun 09, 2016

Migraines tied to increased cardiovascular disease risk among women

AJMPlus | Jun 02, 2016

Statin use may lower infection risk for patients with stroke

AJMPlus | Jun 23, 2016

The DASH diet and metabolic syndrome

AJMPlus | Jun 16, 2016

Racial differences in pain coping

AJMPlus | Jun 02, 2016


Find AJMPlus Issues by Date:





Sign up for AJMPlus



Designed specifically for healthcare professionals in clinical settings, AJM Plus is a FREE, weekly e-mail newsletter. By providing the latest, need-to-know medical headlines and news that affect healthcare professionals and patients, AJM Plus saves you time and keeps you smart. Sign up to receive your complimentary subscription today. Learn more